BioMimetic Therapeutics

BioMimetic Therapeutics Newswire

Comprehensive Real-Time News Feed for BioMimetic Therapeutics.

Results 1 - 5 of 5 in BioMimetic Therapeutics

  1. Life Science Tennessee Now Accepting Venture Forum ApplicationsRead the original story

    Aug 13, 2014 | Customer Interaction Solutions

    ... Biologics and the Life Science Tennessee Board. Lynch is the founder and former president and CEO of BioMimetic Therapeutics, which he led from founding to IPO to ultimate sale of the company. "Presenting companies will receive an unprecedented ...

    Comment?

  2. View Press ReleaseRead the original story

    Jul 28, 2014 | Business Wire

    ... Biologics and the Life Science Tennessee Board. Lynch is the founder and former president and CEO of BioMimetic Therapeutics, which he led from founding to IPO to ultimate sale of the company. "Presenting companies will receive an unprecedented ...

    Comment?

  3. Cool Springs Life Sciences Center adds new tenantRead the original story

    Jun 12, 2014 | Business Journal

    ... in 1,350 square feet of chemistry lab, biology lab and office space. StemSynergy joins CSLSC tenants BioMimetic Therapeutics, the Vanderbilt University Center for Neuroscience Drug Discovery, Pluris Research and Ratliff Histology Consultants, ...

    Comment?

  4. Kuyat v. Biomimetic Therapeutics IncRead the original story

    Mar 28, 2014 | FindLaw

    ... M. Sarafin, individually and on behalf of all others similarly situated, Plaintiff-Appellant, v. BIOMIMETIC THERAPEUTICS, INC., Samuel E. Lynch, and Lawrence E. Bullock, Defendants-Appellees. Before: BOGGS, ROGERS, Circuit Judges; STEEH, District ...

    Comment?

  5. An Unexpected Turn In Wright Medical's Attempts To Get Augment To MarketRead the original story

    Mar 12, 2014 | Seeking Alpha

    ... to a dispute resolution panel if this filing is rejected. Wright Medical 's ( WMGI ) acquisition of BioMimetic Therapeutics and its Augment biological product for bone healing has been almost nothing but trouble. At seemingly every turn the FDA has ...

    Comment?